PedAM
Pediatric Disease Annotations & Medicines
| Disease | muscular dystrophy |
| Symptom | C0878544|cardiomyopathy |
| Sentences | 28 |
| PubMedID- 23352781 | Objectives: this study sought to determine the impact of steroid therapy on cardiomyopathy and mortality in patients with duchenne muscular dystrophy (dmd). |
| PubMedID- 19997769 | How mutations in the protein emerin lead to the cardiomyopathy associated with x-linked emery-dreifuss muscular dystrophy (x-edmd) is unclear. |
| PubMedID- 23418438 | The homozygous mice develop, similarly to human patients, progressive muscular dystrophy associated with dilated cardiomyopathy . |
| PubMedID- 23322878 | A cardiomyopathy in a patient with limb girdle muscular dystrophy type 2a. |
| PubMedID- 20182615 | These diseases include dilated cardiomyopathy with variable muscular dystrophy, dunnigan-type familial partial lipodystrophy, a charcot-marie-tooth type 2 disease, mandibuloacral dysplasia, and hutchinson-gilford progeria syndrome. |
| PubMedID- 20497525 | Kuru et al3 reported a 57-year-old japanese woman with dysferlinopathy manifested as secondary dilated cardiomyopathy attributable to muscular dystrophy. |
| PubMedID- 26050665 | At the age of 23, he was admitted to the hospital for severe dilated cardiomyopathy, and subsequently diagnosed with limb-girdle muscular dystrophy2m (lgmd2m) based on muscle biopsy and gene analysis. |
| PubMedID- 23048029 | Mutations in the lamin a/c gene (lmna) cause a diverse spectrum of diseases, the most common of which is dilated cardiomyopathy often with skeletal muscular dystrophy. |
| PubMedID- 25563468 | Hitherto, they have not been examined in dilated cardiomyopathy in the course of emery-dreifuss muscular dystrophy (edmd). |
| PubMedID- 24969422 | These findings provide new mechanistic and functional insight into cardiomyopathy associated with duchenne muscular dystrophy. |
| PubMedID- 22936362 | Standard optimal medical therapies for heart failure with systolic dysfunction are usedin mtdna disease, with reports of both clinical improvement and progression despitetherapy.48,79 angiotensin-converting enzyme inhibitors have beenshown to slow the onset and progression of cardiomyopathy associated with duchennemuscular dystrophy, and reduce mortality.89 complex device therapy including the use of implantable cardioverterdefibrillators (icds) and cardiac resynchronization therapy should be considered inpatients with mtdna disease provided conventional guidelines are met, including lifeexpectancy of >1 year. |
| PubMedID- 21784508 | This complication was judged most likely to be part of the well described pattern of cardiomyopathy associated with duchenne muscular dystrophy. |
| PubMedID- 25996830 | These findings suggest that reductive stress might contribute to the dilated cardiomyopathy in cases of lamin associated muscular dystrophy. |
| PubMedID- 22655514 | However carvedilol therapy can be safe for patients with dilated cardiomyopathy associated with muscular dystrophy, even producing a modest improvement in systolic and diastolic function (26). |
| PubMedID- 20501885 | The duchenne and becker forms of muscular dystrophy are associated with dilated cardiomyopathy and are diseases in which pulmonary function peaks and then progressively declines. |
| PubMedID- 20960933 | Treatment with 3-blockers or angiotensin ii converting enzyme blockers has been reported to be efficacious for cardiomyopathy in patients with muscular dystrophy. |
| PubMedID- 21596026 | Circulating tenascin-c levels in patients with dilated cardiomyopathy in the course of emery-dreifuss muscular dystrophy. |
| PubMedID- 23400933 | A dilated cardiomyopathy (dcm) is associated with duchenne muscular dystrophy (dmd). |
| PubMedID- 20601155 | Electrocardiographic abnormalities and arrhythmias are strongly associated with the development of cardiomyopathy in muscular dystrophy. |
| PubMedID- 20508850 | Nucleotide metabolism, involving adenylate kinase and creatine kinase appears to be disturbed in the dystrophic mdx heart, and this finding might be useful for the future development of a comprehensive biomarker signature of cardiomyopathy associated with muscular dystrophy. |
| PubMedID- 26085806 | A mutation in bag3(p209l) causes severe childhood muscular dystrophy with cardiomyopathy . |
| PubMedID- 22691118 | This defect also provides a unique biomedical model for human cardiomyopathy associated with muscular dystrophy that may be superior to those available because of the similarities in anatomy and physiology and allow advances in gene therapies for human disease. |
| PubMedID- 22318092 | Dystrophin-deficient duchenne cardiomyopathy is associated with duchenne muscular dystrophy (dmd), the most common lethal muscular dystrophy. |
| PubMedID- 22077867 | Osteopontin--a fibrosis-related marker--in dilated cardiomyopathy in patients with emery-dreifuss muscular dystrophy. |
| PubMedID- 24106506 | Owing to the significant correlation between the tn-c level and lvdd, it was suggested as a new biomarker for detecting cardiomyopathy in patients with emery-dreifuss muscular dystrophy . |
| PubMedID- 23933734 | Mutations in the lamin a/c gene (lmna) encoding a-type nuclear lamins cause dilated cardiomyopathy with variable muscular dystrophy. |
| PubMedID- 22463839 | cardiomyopathy is a consequence of duchenne muscular dystrophy (dmd). |
| PubMedID- 23969225 | The potential for a common mirna therapy that can be applied to multiple forms of muscular dystrophy (md) with a severe cardiomyopathy component has become an attractive option. |
Page: 1